PMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $12.53, but opened at $12.19. PMV Pharmaceuticals shares last traded at $12.17, with a volume of 797 shares.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the stock. Oppenheimer raised their price objective on shares of PMV Pharmaceuticals from $30.00 to $33.00 and gave the stock an “outperform” rating in a report on Thursday, June 9th. HC Wainwright reissued a “buy” rating and set a $63.00 price target on shares of PMV Pharmaceuticals in a research note on Wednesday, June 8th.
PMV Pharmaceuticals Stock Performance
The company’s 50 day moving average price is $14.54 and its 200 day moving average price is $15.30.
Hedge Funds Weigh In On PMV Pharmaceuticals
About PMV Pharmaceuticals
PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.
- Get a free copy of the StockNews.com research report on PMV Pharmaceuticals (PMVP)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- General Mills: Superior Returns With Less Volatility
Receive News & Ratings for PMV Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMV Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.